Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five brokerages that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $32.00.
Several research firms have recently weighed in on GRDN. Truist Financial upped their price objective on Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. Wall Street Zen raised Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Finally, Stephens boosted their price objective on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 14th.
View Our Latest Research Report on Guardian Pharmacy Services
Hedge Funds Weigh In On Guardian Pharmacy Services
Guardian Pharmacy Services Stock Up 2.9%
Shares of GRDN stock opened at $33.84 on Friday. Guardian Pharmacy Services has a 12-month low of $17.78 and a 12-month high of $37.43. The firm has a fifty day moving average of $30.38 and a 200-day moving average of $27.51. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of 53.71 and a beta of 0.96.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last announced its earnings results on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.01. The firm had revenue of $377.43 million during the quarter, compared to analyst estimates of $381.16 million. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. On average, equities analysts expect that Guardian Pharmacy Services will post 0.87 EPS for the current year.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- Trade this between 9:30 and 10:45 am EST
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- The buying spree that no one is talking about
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
